> The cancer drug needs two million. Anthropic gets 2 trillion.
There is rightfully a lot of skepticism about whether Anthropic can maintain their business in the face of competition, especially from open weights models. But it's undeniable that they do have a product that works at doing useful things, right now.
Presumably that cancer drug, important as it would be if it succeeds, is not currently guaranteed to produce any useful result at all (even with enough funding).
In the face of competition!? In the face of their own debts and commitments!
I feel like this is an unnecessarily pedantic point? Global funding for cancer research from 2016 - 2023 was around $50 billion [0] with the vast majority coming from public funds (ie taxes on most of the rest of us).
Meanwhile, the ultra-wealthy are dumping upwards of $2 trillion in capital purely for the sake of speculatively betting on it increasing their capital.
In our society, that capital translates to labor, time, research facilities, technology. Which effectively means that our current system of governance and wealth distribution prioritizes growing capital 200x (40 x 5 years) more than solving a fundamental human disease that has plagued us since we first crawled out of the ocean.
I don't think it's wrong to say 'hey maybe our priorities are a bit mixed and just getting more capital for the sake of it maybe defeats the purpose'.
[0] https://www.thelancet.com/journals/lanonc/article/PIIS1470-2...